Compounds > 3,4-dihydroxyphenylacetaldehyde
Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and tolcapone

3,4-dihydroxyphenylacetaldehyde has been researched along with tolcapone in 1 studies

Compound Research Comparison

Studies
(3,4-dihydroxyphenylacetaldehyde)		Trials
(3,4-dihydroxyphenylacetaldehyde)		Recent Studies (post-2010)
(3,4-dihydroxyphenylacetaldehyde)		Studies
(tolcapone)		Trials
(tolcapone)		Recent Studies (post-2010) (tolcapone)
9905041382132

Protein Interaction Comparison

ProteinTaxonomy3,4-dihydroxyphenylacetaldehyde (IC50)tolcapone (IC50)
TransthyretinHomo sapiens (human)3.2
Catechol O-methyltransferaseHomo sapiens (human)0.043
Catechol O-methyltransferaseRattus norvegicus (Norway rat)0.4661
Adenosine receptor A2aHomo sapiens (human)0.93
Genome polyproteinDengue virus 2 Thailand/16681/840.64

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Goldstein, DS; Isonaka, R; Jinsmaa, Y; Sharabi, Y1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and tolcapone

ArticleYear
3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
    The Journal of pharmacology and experimental therapeutics, 2020, Volume: 372, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; alpha-Synuclein; Antioxidants; Cell Line; Copper; Dopamine; Humans; Monoamine Oxidase; Monophenol Monooxygenase; Oligodendroglia; Oxidation-Reduction; Parkinson Disease; Protein Binding; Protein Conformation; Tolcapone

2020